Viropro Inc. Update on the Business Plan

Published: Mar 17, 2011

IRVINE, Calif.--(BUSINESS WIRE)--VIROPRO (Pink Sheets: VPRO) wishes to update the investment community. Viropro’s mission is to become a premier provider of outsourced research, development and manufacturing services for the biopharmaceutical industry. To this end, over the past several months, the Company has actively implemented its business plan for biotech Contractual Research and Manufacturing Services. The Spectrum Pharmaceuticals Agreement, disclosed on January 5, 2011, is an excellent example of the future of Biotech “CRAMS.”

Back to news